You just read:

Steba Biotech Announces Positive Top-Line Results from its Latin American Phase 3 Clinical Trial of TOOKAD® in Patients with Localized Prostate Cancer and Obtains First Marketing Authorization in Mexico

News provided by

Steba Biotech

01 Feb, 2016, 12:30 GMT